Pharmacological Management of Dyslipidemia in Atherosclerosis: Limitations, Challenges, and New Therapeutic Opportunities
2019
Clinical and epidemiological studies during the last 7 decades indicated that elevated low-density lipoprotein cholesterol (LDL-C) levels and reduced high-density lipoprotein cholesterol (HDL-C) le...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
102
References
9
Citations
NaN
KQI